Halozyme
Showing 1 - 25 of 47
Pancreatic Cancer, Advanced Pancreatic Ductal Adenocarcinoma Trial in United States (Gemcitabine, Nab-paclitaxel, PEGPH20)
Active, not recruiting
- Pancreatic Cancer
- Advanced Pancreatic Ductal Adenocarcinoma
- Gemcitabine
- +2 more
-
Hartford, Connecticut
- +9 more
Jul 15, 2022
Hereditary Angioedema Trial in United States (CINRYZE with rHuPH20)
Completed
- Hereditary Angioedema
- CINRYZE with rHuPH20
-
Scottsdale, Arizona
- +3 more
Jun 16, 2021
Pancreatic Ductal Adenocarcinoma Trial in New York (Atezolizumab, PEGPH20)
Terminated
- Pancreatic Ductal Adenocarcinoma
-
New York, New YorkColumbia University
Dec 1, 2020
Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma Trial in Worldwide (5-Fluorouracil
Recruiting
- Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma
- 5-Fluorouracil (5-FU)
- +11 more
-
Scottsdale, Arizona
- +41 more
Jan 19, 2023
Pancreatic Ductal Adenocarcinoma Trial in Philadelphia (Pegvorhyaluronidase alfa, Abraxane, Gemcitabine)
Withdrawn
- Pancreatic Ductal Adenocarcinoma
- Pegvorhyaluronidase alfa
- +2 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center at University of Pennsylvania
Jan 30, 2020
Metastatic Breast Cancer Trial in United States (Eribulin mesylate, Biologic: PEGylated recombinant human hyaluronidase
Terminated
- Metastatic Breast Cancer
- Eribulin mesylate
- +2 more
-
Whittier, California
- +6 more
Jun 25, 2020
Dermatitis, Allergic Contact Trial in Michigan City (rHuPH20, Placebo)
Completed
- Dermatitis, Allergic Contact
- rHuPH20
- Placebo
-
Michigan City, IndianaSymbio Phase I Unit, Saint Anthony Memorial Research Center
Nov 19, 2021
Chronic Wounds Trial in Harbin (HA35(L20200708MP07707, Ministry of Health, Mongolia)was freshly manufactured by mixing
Completed
- Chronic Wounds
- HA35(L20200708MP07707, Ministry of Health, Mongolia)was freshly manufactured by mixing hyaluronidase PH20 injectable solution (H31022111) and high-molecular-weight HA injectable solution (H20174089)
-
Harbin, Heilongjiang, ChinaFar East Hospital
Mar 1, 2023
HIV Antibodies Trial run by the NIAID (VRC-HIVMAB091-00-AB, EDP)
Completed
- HIV Antibodies
- VRC-HIVMAB091-00-AB
- EDP
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 8, 2022
Metastatic Pancreatic Adenocarcinoma Trial in United States (PEGPH20, Oxaliplatin, Leucovorin)
Active, not recruiting
- Metastatic Pancreatic Adenocarcinoma
- PEGPH20
- +4 more
-
Anchorage, Alaska
- +153 more
Nov 29, 2021
Metastatic Pancreatic Cancer Trial in United States (PEGPH20, Nab-paclitaxel, Gemcitabine)
Pancreatic Ductal Carcinoma Trial in Worldwide (Biological: PEGylated Recombinant Human Hyaluronidase (PEGPH20), Placebo,
Terminated
- Pancreatic Ductal Carcinoma
- Biological: PEGylated Recombinant Human Hyaluronidase (PEGPH20)
- +3 more
-
Mobile, Alabama
- +216 more
Jun 30, 2020
NSCLC, Gastric Cancer Trial in United States (PEGPH20, Pembrolizumab)
Completed
- NSCLC
- Gastric Cancer
-
Birmingham, Alabama
- +27 more
Jan 24, 2020
Type 1 Diabetes Trial in Chula Vista (Rapid Acting insulin with pre-treatment of rHuPH20, Sham injection)
Completed
- Type 1 Diabetes Mellitus
- Rapid Acting insulin with pre-treatment of rHuPH20
- Sham injection
-
Chula Vista, CaliforniaProfil Institute for Clinical Research
Jan 30, 2019
Type 1 Diabetes Trial in Chula Vista (Sham Injection, Recombinant human hyaluronidase PH20, Insulin aspart)
Completed
- Type 1 Diabetes Mellitus
- Sham Injection
- +3 more
-
Chula Vista, CaliforniaProfil Institute for Clinical Research
Feb 5, 2019
Type 1 Diabetes Trial in Chula Vista (Humalog, Humulin-R, Recombinant human hyaluronidase PH20 (rHuPH20))
Completed
- Type 1 Diabetes Mellitus
- Humalog
- +3 more
-
Chula Vista, CaliforniaProfil Institute for Clinical Research, Inc.
Feb 4, 2019
Cholangiocarcinoma Non-resectable, Cholangiocarcinoma, Intrahepatic, Cholangiocarcinoma, Extrahepatic Trial in Korea, Republic
Terminated
- Cholangiocarcinoma Non-resectable
- +3 more
- PEGPH20
- +3 more
-
Phoenix, Arizona
- +35 more
Jan 24, 2020
Healthy Trial in Kalamazoo (recombinant human hyaluronidase)
Completed
- Healthy
- recombinant human hyaluronidase
-
Kalamazoo, MichiganJasper Clinic
Sep 18, 2018
NSCLC Trial in United States (PEGylated recombinant human hyaluronidase PH20, Docetaxel)
Terminated
- Non-small Cell Lung Cancer
- PEGylated recombinant human hyaluronidase PH20
- Docetaxel
-
Encinitas, California
- +7 more
Feb 5, 2019
Risk Factors for or a Diagnosis of Osteoporosis Trial in San Antonio (rHuPH20, zoledronic acid)
Completed
- Risk Factors for or a Diagnosis of Osteoporosis
- rHuPH20
- zoledronic acid
-
San Antonio, TexasHealthcare Discoveries, LLC/ICON Development Solutions
Aug 13, 2018
Diabetes, Type 1 Trial in United States (Insulin lispro, recombinant human hyaluronidase PH20, Insulin aspart)
Completed
- Diabetes Mellitus, Type 1
- Insulin lispro
- +4 more
-
Escondido, California
- +18 more
Feb 5, 2019
Diabetes Trial in San Antonio (Humalog, Humulin-R, Recombinant human hyaluronidase PH20 (rHuPH20))
Completed
- Diabetes Mellitus
- Humalog
- +2 more
-
San Antonio, TexasDiabetes and Glandular Disease Research, Inc.
Feb 4, 2019
Dehydration Trial (Oral rehydration fluid, Isotonic hydration fluid and recombinant human hyaluronidase)
Withdrawn
- Dehydration
- Oral rehydration fluid
- Isotonic hydration fluid and recombinant human hyaluronidase
- (no location specified)
May 5, 2017